CPT 16032: Surgical Skin/Tissue Procedure, Outpatient

CPT code 16032 denotes a procedural skin/tissue intervention performed in an outpatient setting and is used in billing for surgical or dermatologic procedures. Nationally, precise procedural codes like 16032 matter because they drive claims processing, influence payment determinations, and affect clinical documentation standards used across payers. This publication reviews coverage and billing considerations relevant to major payers and Medicare and provides context for clinical and administrative stakeholders.

Key payers covered include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of how the code is used in practice, comparative payer coverage presence, and implications for coding consistency. The report summarizes standard sites of service and service type, highlights common policy themes affecting procedural dermatologic and minor surgical billing, and outlines the types of benchmarks and policy updates readers can expect to consult when applying 16032 in clinical billing workflows.

This summary is intended to serve hospital billing departments, ambulatory surgery centers, dermatology and surgical practices, and payers seeking a national perspective on procedural skin/tissue coding for administrative and policy review.

Billing Code Overview

CPT code 16032 represents a procedure described as "16032". Based on the code description, the service type is a surgical or procedural skin/tissue intervention. The typical site of service for this type of procedure is an outpatient ambulatory surgery center or hospital outpatient department.

Data not available in the input.

Clinical Context

A typical patient is an adult presenting to an outpatient dermatology clinic with a small superficial benign lesion such as a common wart, molluscum contagiosum, or actinic keratosis requiring chemical destruction. The clinician evaluates the lesion, documents size, location, number of lesions, prior treatments, informed consent, and selects an appropriate topical caustic agent (for example, trichloroacetic acid). The procedure is performed in the clinic exam room with topical or no anesthesia; the provider applies the chemical agent to the lesion(s) until the desired chemical effect is achieved. Post-procedure instructions are provided for wound care and signs of infection, and a follow-up is arranged if healing concerns arise. Typical site of service is an outpatient dermatology office or ambulatory care clinic. Service type: chemical application for skin lesion destruction (destructive procedure).

Coding Specifications

Modifier	Description	When to Use
`25`	Significant, separately identifiable evaluation and management service on the same day as the procedure	When a distinct E/M visit is documented in addition to the destructive procedure
`26`	Professional component

Taxonomy Code	Specialty	Notes
207N00000X	Dermatology	Primary specialty performing skin lesion destruction
207P00000X	Mohs Micrographic Surgery	Dermatologic surgeons performing lesion destruction when part of broader skin cancer care
208000000X	Family Medicine	Primary care clinicians who may perform minor skin lesion destruction
208D00000X	General Practice	Office-based providers who perform simple cutaneous destructive procedures
363L00000X	Physician Assistant	Midlevel providers commonly performing office-based dermatologic procedures

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`B07.9`	Viral wart, unspecified	Common indication for chemical destruction of warts
`B08.1`	Molluscum contagiosum	Benign viral lesions amenable to office-based destructive therapy
`L57.0`	Actinic keratosis	Precancerous lesions frequently treated with destructive modalities
`L91.8`	Other hypertrophic disorders of skin	Includes benign hyperkeratotic lesions that may be destructively treated
`D23.9`	Benign neoplasm of skin, unspecified	General diagnosis for benign skin lesions treated with destruction
`L82.1`	Solar keratosis of scalp and neck	Specific site-related actinic damage treated with destruction
`K12.0`	Recurrent oral aphthae	When superficial mucosal lesions in the oral cavity require topical destructive treatment (less common)

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`17000`	Destruction (e.g., laser surgery, electrosurgery, cryosurgery, chemosurgery), first lesion	Often used when a different destructive modality (cryotherapy/laser/electrosurgery) is selected for the first lesion instead of chemical destruction
`17003`	Destruction, second through four lesions, each	Billed when multiple additional benign lesion destructions are performed in the same session using non-chemical modalities
`11100`	Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure)	Performed when diagnosis is uncertain and tissue sampling is required prior to or instead of destructive treatment
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes	Used when a significant, separately identifiable E/M service is provided on the same day as the procedure
`99024`	Postoperative follow-up visit, included in global service; for general reporting when required by payer	Used in documentation of routine postoperative/wound check visits when payer requires separate coding

OpenPayer

Summary & Overview